Affordable Access

Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters.

Authors
  • Valet, G
  • Repp, R
  • Link, H
  • Ehninger, A
  • Gramatzki M, M
Type
Published Article
Journal
Cytometry. Part B, Clinical cytometry
Publication Date
May 01, 2003
Volume
53
Issue
1
Pages
4–10
Identifiers
PMID: 12717685
Source
Medline
License
Unknown

Abstract

The comparatively accurate pretherapeutic identification of high-risk AML patients may prove useful for the development of individualized therapy protocols in stratified clinical patients groups.

Report this publication

Statistics

Seen <100 times